Criteria, Scope & Restrictions

CRITERIA

Applications must demonstrate excellence in the following criteria categories:

  • Inspired innovation: Application exhibits a thoughtful, creative and innovative approach to optimizing patient outcomes through collaborative decision-making. A solution is clearly identified either through:
    • Existing program to be grown or expanded;
    • Pilot project with measurable results; or
    • New data-based idea that requires initial funding
  • Measurable impact: Application should clearly describe how patients’ lives will be improved, enhanced or transformed through clearly defined goals and milestones.
  • Metrics for success: Application should include qualitative and/or quantitative milestones and metrics that demonstrate how program will be evaluated, monitored and improved upon.

SCOPE AND RESTRICTIONS

  • Applications are restricted to patient and professional organizations and associations with an interest in hematology, oncology and immune-inflammatory conditions in disease areas where Celgene has either a clinical or commercial interest.
  • Applicants must be qualified not-for-profit entities under IRS rules and headquartered in the United States.
  • Consideration for awards will not be given to individuals, medical facilities or research institutions. Nor will applications be accepted for pre-clinical, clinical or translational research programs.
  • Each Applicant may submit only one entry for one specific activity or program.
  • Applications will be accepted for:
    • Existing program to be grown or expanded;
    • Pilot project with measurable results; or
    • New data-based idea that requires initial funding
  • Applications must propose a solution to optimizing patient outcomes through collaborative decision-making.
  • Applications must be submitted using the online application form found at http://www.innovationimpact.com.

Organizations must submit a completed application form by the deadline: 11:59 pm EDT, Friday, July 28, 2017.